Mesoblast (MESO) Income towards Parent Company (2015 - 2025)

Mesoblast's (MESO) quarterly Income towards Parent Company came in at -$40.2 million in Q4 2025, up 16.21% year-on-year from -$34.6 million in Q4 2024, and up 16.21% quarter-over-quarter from -$47.9 million in Q2 2025.

Mesoblast (MESO) Income towards Parent Company (2015 - 2025) Analysis & Trends

Mesoblast has disclosed Income towards Parent Company across 11 years of filings, most recently posting -$40.2 million for Q4 2025.

  • Income towards Parent Company for Q4 2025 came in at -$40.2 million, up 16.21% year-over-year; the trailing twelve-month figure through Dec 2025 was -$168.6 million (down 9.19% YoY), and the FY2025 annual result was -$102.1 million, down 16.13% from the prior year.
  • Income towards Parent Company came in at -$40.2 million for Q4 2025 at Mesoblast, up from -$47.9 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $26.5 million in Q1 2021 to a low of -$76.8 million in Q2 2021.
  • The 5-year median for Income towards Parent Company is -$32.5 million (2023), against an average of -$26.0 million.
  • Across the five-year window, Income towards Parent Company soared 73.72% in 2021 and plunged 381.52% in 2023, its largest moves.
  • Mesoblast's Income towards Parent Company stood at $25.9 million in 2021, then fell by 5.62% to $24.5 million in 2022, then sank by 232.89% to -$32.5 million in 2023, then sank by 47.31% to -$47.9 million in 2024, then grew by 16.21% to -$40.2 million in 2025.
  • The last three Income towards Parent Company figures came in at -$40.2 million (Q4 2025), -$47.9 million (Q2 2025), and -$47.9 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mesoblast 21.68 Bn 21.55 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -40.16 Mn
Jun 30, 2025 -47.93 Mn
Dec 31, 2024 -47.93 Mn
Jun 30, 2024 -32.54 Mn
Dec 31, 2023 -32.54 Mn
Jun 30, 2023 -41.37 Mn
Mar 31, 2023 -59.97 Mn
Dec 31, 2022 24.49 Mn
Sep 30, 2022 -16.88 Mn
Jun 30, 2022 -69.89 Mn
Mar 31, 2022 21.30 Mn
Dec 31, 2021 25.95 Mn
Sep 30, 2021 -22.65 Mn
Jun 30, 2021 -76.75 Mn
Mar 31, 2021 26.52 Mn
Dec 31, 2020 25.69 Mn
Sep 30, 2020 -24.54 Mn
Jun 30, 2020 -45.33 Mn
Mar 31, 2020 15.26 Mn
Dec 31, 2019 24.58 Mn